期刊文献+

幽门螺杆菌粘膜疫苗的研究进展 被引量:4

Progress in research of Hp mucosal vaccine
下载PDF
导出
摘要 胃窦部幽门螺杆菌(Helicobacter pylori,Hp)感染可引起许多胃十二指肠疾病,包括B型(胃窦)胃炎、消化性溃疡、胃粘膜相关淋巴组织淋巴瘤和胃癌。临床上对Hp感染的治疗主要采用以抗生素为主的治疗方案,虽可在一定程度治愈Hp感染,但不能预防Hp再感染,同时抗生素的使用可导致Hp耐药菌株的产生和带来许多严重的副作用,而Hp疫苗可以解决这一难题,使得Hp疫苗接种成为了根治Hp感染和预防再感染的唯一方法。目前,Hp疫苗的研究进展迅速,粘膜疫苗以其有效的保护性免疫效果成为这一研究的热点。我们对Hp粘膜疫苗的组成、接种途径、免疫效果及保护性免疫机制等方面的研究进展加一综述。
作者 吴超 邹全明
出处 《世界华人消化杂志》 CAS 2000年第2期203-205,共3页 World Chinese Journal of Digestology
关键词 幽门螺杆菌 粘膜疫苗 免疫 Helicobacter pylori mucosal vaccine immunity
  • 相关文献

参考文献16

  • 1[1]Michetti P,Corthesy-Theulaz I,Davin C,Haas R,Vaney AC,Heitz M,Bille J,Kraehenbuhl JP,Saraga E,Blum AL.Immunization of Balb / c mice against Helicobacter felis infection with Helicobacter pylori urease.Gastroenterology,1994; 107:1002 - 1011
  • 2[2]Corthesy-Theulaz I,Porta N,Glauser M,Saraga E,Vaney AC,Haas R,Kraehenbuhl JP,Blum AL,Michetti P.Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice.Gastroenterology,1995;109:115-121
  • 3[3]Guy B,Hessler C,Fourage S,Haensler J,Vialon-Lafay E,Rokbi B,Millet MJ.Systemic immunization with urease protects mice against Helicobacter pylori infection.Vaccine,1998; 16:850 - 856
  • 4[4]Lee A,Chen MH.Successful immunization against gastric infection with Helicobacter species:use of a cholera toxin B-subunit-whole-cell vaccine.Infect Immune,1994; 62:3594 - 3597
  • 5[5]Blanchard TG,Lycke N,Czinn SJ,Nedrud JG.Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.Immunology,1998;94:22-27
  • 6[6]Monath TP,Kleathous H,Lee CK.Development of recombinant Helicobacter pylori urease as an oral Vaccine:Current status (abstract).Gut,1995;37(Suppl 1):A52
  • 7[7]Myers GA,Ermak TH,Georgakopulos K,Tibbitts T,Ingrassia J,Gray H,Kleanthous H,Lee CK,Monath TP.Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.Vaccine,1999; 17:1394 - 1403
  • 8[8]Marchetti M,Rossi M,Giannelli V,Giuliani MM,Pizza M,Censini S,Covacci A,Massari P,Pagliaccia C,Manetti R,Telford JL,Douce G,Dougan G,Rappuoli R,Ghiara P.Protection against Helicobacter pylori infection in mice by intragastric vaccination with H.pylori antigens is achieved using a non-toxic mutant of E.coli heat-labile enterotoxin (LT) as adjuvant.Vaccine,1998; 16:33 - 37
  • 9[9]Radcliff FJ,Hazell SL,Kolesnikow T,Doidge C,Lee A.Catatase,a novel antigen for Helicobacter pylori vaccination.Infect Immune,1997; 65:4668 -4671
  • 10[10]Challacomde SJ,Rahman D,O'Hagan DT.Salivary,gut,vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.Vaccine,1997; 15:159

同被引文献113

  • 1Fu-Sheng Wang Li-He Xing Ming-Xu Liu Chuan-Lin Zhu Hui-Gang Liu Hui-Fen Wang Zhou-Yun Lei Division of Biological Engineering,~2 Fourth Department of Liver Diseases,Beijing Institute of Infectious Diseases,Beijing Hospital of Infectious Diseases,Beijing 100039,China.Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection[J].World Journal of Gastroenterology,2001,7(4):537-541. 被引量:131
  • 2张光曙,甘天福,赵汇川,杜庆岭,于建国,丁明权.免疫调节剂胎盘肽治疗丙型肝炎[J].实用医药杂志,1996,14(4):215-217. 被引量:2
  • 3张锦坤,于君.胃幽门螺杆菌与胃癌发病机制关系的分子生物学研究[J].临床消化病杂志,1993,5(3):97-102. 被引量:18
  • 4纪小龙.新发现与肝炎肝肿瘤有关的病源体—肝螺杆菌[J].新消化病学杂志,1996,4(10):572-572. 被引量:3
  • 5Gotteland M, Corvalan A, Sarmiento F, Chavez E, Backouse C,Palma M, Kakarieka E, Vial MT, Figueroa G. Gastric permeability is not increased in children colonized by CagA-positive strains of Helicobacter pylori. Did Liver Dis 2001;33:750-754.
  • 6Dundon WG, Nishioka H, Polenghi A, Papinutto E, Zanotti G, Montemurro P, Del GG, Rappuoli R, Montecucco C.The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol 2002;291:545-550.
  • 7Londono-Arcila P, Freeman D, Kleanthous H, O'Dowd AM,Lewis S, Turner AK, Rees EL, Tibbitts TJ, Greenwood J, Monath TP, Darsley MJ. Attenuated salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming parenteral boosting vaccination regimen. Infect Immun 2002;70:5096-5106.
  • 8Raghavan S, Svennerholm AM, Holmgren J. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.Infect Immun 2002;70:4621-4627.
  • 9Keller WC, Michetti P. Vaccination against Helicobacter pylorian old companion of man. Expert Opin Biol Ther 2001;1:795-802.
  • 10Nilsson CL. Bacterial proteomics and vaccine development.Am J Pharmacogenomics 2002;2:59-65.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部